Trevor Hawkins

Resistell proposes an alternative to culture based antibiogram, the current gold standard in antibiotic susceptibility testing. Our offering is a diagnostic device. The rapid AST method is based on the detection of movement caused by living bacterial cells. Because the test is growth independent rapid AST, we reduce the time taken to get a result from days to minutes. Resistell provides information on which antibiotic should be used to treat the patient, and the concentration at which it should be administered.

Featuring talented young musicians from over 30 local schools, YMMC's Junior Youth and Honors Orchestras present three acclaimed symphonic concerts at Sunset Center each year. Three chamber music programs, including the Chamber Players, Brass Ensemble, and Woodwind Ensemble, focus on the intensive study of small-group music and give back to their communities through benefit concerts. And our South County Strings program reaches over 200 students each year in rural South Monterey County communities with free group string instruction and low-cost instrument rentals.

Lifespin GmbH, a deep data company developing a proprietary AI-based health testing platform to measure quantitative metabolic data in patient samples. Our platform is based on mapping metabolomics for human health and translating that data into health information that can be deployed in a wide range of pharmaceutical, research, and clinical settings. Lifespin’s health diagnostics software will be applicable in the broader healthcare space ranging from diagnostics to patient stratification and personalized medicine, as well as supporting the drug discovery process.

GNA Biosolutions is a private molecular diagnostics company located in Germany. Our proprietary technology, Pulse Controlled Amplification (PCA), offers a novel, ultrafast, and cost-effective molecular diagnostic platform that captures and amplifies nucleic acids from complex clinical samples. PCA assays are being developed for a number of therapeutic areas, including infectious diseases and biothreats. Nucleic acid amplification is a fundamental process in molecular biology, with a multitude of applications. In collaboration with our partners around the world, our PCA technology is taking molecular testing to places it’s never been able to go before. Our vision is to bring the power of molecular testing, from sample to answer, to everyone, everywhere. For more information, please visit www.gna-bio.com

Noscendo GmbH, a Duisburg (Germany) based molecular diagnostics company, changes the way infection causative microbes are identified. Introducing a paradigm shift using proprietary algorithms and software harnessing next generation sequencing of cell free nucleic acids isolated from patient samples Noscendo brings the concept of liquid biopsy into the field of infectious diseases. Noscendo’ s software solution is capable of differentiating infection from non-infectious signals and thereby aiding intensive care clinicians in their daily task to find the right decisions, enabling a targeted and successful treatment in an actionable timeframe.

Resistell proposes an alternative to culture based antibiogram, the current gold standard in antibiotic susceptibility testing. Our offering is a diagnostic device. The rapid AST method is based on the detection of movement caused by living bacterial cells. Because the test is growth independent rapid AST, we reduce the time taken to get a result from days to minutes. Resistell provides information on which antibiotic should be used to treat the patient, and the concentration at which it should be administered.

Featuring talented young musicians from over 30 local schools, YMMC's Junior Youth and Honors Orchestras present three acclaimed symphonic concerts at Sunset Center each year. Three chamber music programs, including the Chamber Players, Brass Ensemble, and Woodwind Ensemble, focus on the intensive study of small-group music and give back to their communities through benefit concerts. And our South County Strings program reaches over 200 students each year in rural South Monterey County communities with free group string instruction and low-cost instrument rentals.

Lifespin GmbH, a deep data company developing a proprietary AI-based health testing platform to measure quantitative metabolic data in patient samples. Our platform is based on mapping metabolomics for human health and translating that data into health information that can be deployed in a wide range of pharmaceutical, research, and clinical settings. Lifespin’s health diagnostics software will be applicable in the broader healthcare space ranging from diagnostics to patient stratification and personalized medicine, as well as supporting the drug discovery process.

GNA Biosolutions is a private molecular diagnostics company located in Germany. Our proprietary technology, Pulse Controlled Amplification (PCA), offers a novel, ultrafast, and cost-effective molecular diagnostic platform that captures and amplifies nucleic acids from complex clinical samples. PCA assays are being developed for a number of therapeutic areas, including infectious diseases and biothreats. Nucleic acid amplification is a fundamental process in molecular biology, with a multitude of applications. In collaboration with our partners around the world, our PCA technology is taking molecular testing to places it’s never been able to go before. Our vision is to bring the power of molecular testing, from sample to answer, to everyone, everywhere. For more information, please visit www.gna-bio.com

Noscendo GmbH, a Duisburg (Germany) based molecular diagnostics company, changes the way infection causative microbes are identified. Introducing a paradigm shift using proprietary algorithms and software harnessing next generation sequencing of cell free nucleic acids isolated from patient samples Noscendo brings the concept of liquid biopsy into the field of infectious diseases. Noscendo’ s software solution is capable of differentiating infection from non-infectious signals and thereby aiding intensive care clinicians in their daily task to find the right decisions, enabling a targeted and successful treatment in an actionable timeframe.